Machine-learning-guided library screening and drug resistance profiling of HIV-1 protease inhibitors.
Coupling ML-based large-scale prioritization with structure-based and dynamical validation can prospectively enrich for resistance-robust HIV-1 protease inhibitors and provide a generalizable framework for anticipating drug resistance in rapidly evolving viral targets.